High prevalence of non-steroidal anti-inflammatory drug use among acute kidney injury survivors in the southern community cohort study. | Vanderbilt Translational and Clinical Cardiovascular Research Center (VTRACC)

Lipworth L, Abdel-Kader K, Morse J, Stewart TG, Kabagambe EK, Parr SK, Birdwell KA, Matheny ME, Hung AM, Blot WJ, Ikizler TA, Siew ED. High prevalence of non-steroidal anti-inflammatory drug use among acute kidney injury survivors in the southern community cohort study. BMC nephrology. 2016 Nov 24;17(17). 189 p. PMID: 27881100 [PubMed] PMCID: PMC5122006

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used and have been linked to acute kidney injury (AKI), chronic kidney disease (CKD) and cardiovascular disease (CVD). Patients who survive an AKI episode are at risk for future adverse kidney and cardiovascular outcomes. The objective of our study was to examine the prevalence and predictors of NSAID use among AKI survivors.